‘Conflation’ Between Disease Info, Drug Advertisement Called Out By FDA

By Jessica Karins / July 30, 2024 at 5:09 PM
FDA warns that patient confusion could occur when drug companies sponsor communications about a disease their product treats, especially if the message is similar to or in close proximity to advertising of the drug itself. In a blog post the Center for Drug Evaluation and Research (CDER) says disease awareness communications are causing confusion about the benefits of a drug. Disease awareness communications typically focus on symptoms of a medical condition and advise speaking to a health care provider about...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.